AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.
研究兴趣

论文共 268 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells
Timo K van den Berg,Hugo Olsman,Hanke L Matlung,Katka Franke,Imke Lodewijks,Lilian Driessen-Engels, Mary J van Helden, Seline A Zwarthoff, Roel J Arends, Inge M J Reinieren-Beeren, Marc C B C Paradé, Karin de Laat-Arts,
Journal for ImmunoTherapy of Cancerno. 4 (2023): e006567-e006567
引用1浏览0WOS引用
1
0
Abstract 2934: BYON4228, an antagonistic SIRPα mAb with a unique and favorable preclinical profile compared to three comparator SIRPα mAbs
Mary van Helden, Seline A. Zwarthoff, Roel Arends, Inge Reinieren-Beeren,Marc Paradé, Lilian Driessen-Engels, Karin de Laat-Arts, Desirée Damming, Ellen Santegoeds-Lenssen, Daphne van Kuppeveld, Imke Lodewijks,Ellen Mattaar,
Cancer Researchno. 7_Supplement (2023): 2934-2934
引用0浏览0引用
0
0
BYON4228, an antagonistic SIRP mAb with a unique and favorable preclinical profile compared to three comparator SIRPa mAbs
Mary van Helden, Seline Zwarthoff, Roel Arends, Inge Reinieren-Beeren,Marc Parade, Lilian Driessen-Engels, Karin de Laat-Arts, Desiree Damming, Ellen Santegoeds-Lenssen, Daphne van Kuppeveld, Imke Lodewijks,Ellen Mattaar,
CANCER RESEARCHno. 7 (2023)
引用0浏览0引用
0
0
BYON4228 is a pan-allelic SIRP alpha antibody that potentiates killing of antibody-opsonized tumor cells and lacks binding to T cells
Mary van Helden, Seline Zwarthoff,Hugo Olsman, Marc Parade, Ellen Mattaar, Karin de laat,Imke Lodewijks, Paul Boersema,Lilian Driessen-Engels, Jorien Sanderink, Wendy Kappers, Diels van den Dobbelsteen,
ANNALS OF ONCOLOGY（2022）
引用0浏览0引用
0
0
495 BYON4228, a pan-allelic SIRPα blocking antibody with a favorable pre-clinical safety profile, enhances anti-tumor immunity in vitro and in vivo
Mary van Helden, Roel Arends, Seline Zwarthoff,Monique van der Vleuten,Marc Paradé, Karin de Laat-Arts,Hugo Olsman,Ellen Mattaar,Dirk Glaudemans, Daniëlle van Wijk, Lilian Driessen-Engels, Inge Reinieren-Beeren,
Regular and Young Investigator Award Abstracts (2022)
引用0浏览0引用
0
0
BYON4228, A PAN-ALLELIC SIRPa BLOCKING ANTIBODY WITH A FAVORABLE PRE-CLINICAL SAFETY PROFILE, ENHANCES ANTI-TUMOR IMMUNITY IN VITRO AND IN VIVO
Mary Van Helden, Roel Arends, Seline Zwarthoff,Monique Van der Vleuten,Marc Parade, Karin De laat-Arts,Hugo Olsman,Ellen Mattaar,Dirk Glaudemans, Danielle Van Wijk,Lilian Driessen-Engels, Inge Reinieren-Beeren,
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022): A516-A516
引用0浏览0引用
0
0
加载更多
作者统计
  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn